Craft

2cureX

Stock Price

KR0.5

2024-10-29

Market Capitalization

KR8.4 M

2024-10-29

2cureX Summary

Company Summary

Overview
2cureX is a biotech company that helps physicians to select an individual drug therapy for their cancer patients. It develops the IndiTreat test, a functional precision medicine test that allows physicians to match the individual cancer patient with the most effective cancer drug treatment. The company serves cancer hospitals and oncology clinics.
Type
Public
Status
Active
Founded
2006
HQ
Copenhagen, DK | view all locations
Website
https://www.2curex.com/
Cybersecurity rating
Sectors

Key People

  • Povl-Andre Bendz
  • Fernando Andreu
  • Ole Thastrup

    Ole Thastrup, CSO and Deputy CEO, Director

  • Nils Brünner

    Nils Brünner, Director

    LocationsView all

    2 locations detected

    • Copenhagen HQ

      Denmark

      Fruebjergvej 3

    • Hamburg, HH

      Germany

      Röntgenstraße 24

    2cureX Financials

    Summary Financials

    Gross profit (FY, 2025)
    kr10.0K
    Net income (FY, 2025)
    (kr2.6M)
    Cash (FY, 2025)
    kr2.1M
    EBIT (FY, 2025)
    (kr2.8M)

    Footer menu